<DOC>
	<DOCNO>NCT00638092</DOCNO>
	<brief_summary>The purpose trial determine whether iodide supplementation neonate bear 31 week gestation improve neurodevelopment measure two year age .</brief_summary>
	<brief_title>A Randomised Controlled Trial Iodide Supplementation Preterm Infants Follow-up 2 Years</brief_title>
	<detailed_description>Iodine essential synthesis thyroxine , thyroxine essential normal brain development utero first 2-3 year life . The recommended iodine intake parenteral nutrition regimens 1 Î¼g/kg/day commercially available parenteral solution infant reflect recommendation . In absence iodine source , infant vulnerable negative iodine balance insufficiency . As many preterm infant feed parenterally prolong period solution show iodine-deficient , I2S2 Trial design UK multicentre randomise control trial establish whether iodine supplementation preterm infant benefit neurodevelopment .</detailed_description>
	<mesh_term>Iodine</mesh_term>
	<criteria>All infant bear 31 week gestation Mother expose excess iodine pregnancy delivery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>42 Hours</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>hypothyroxinemia</keyword>
	<keyword>preterm infant</keyword>
	<keyword>iodine</keyword>
	<keyword>neurodevelopmental outcome</keyword>
	<keyword>Iodine supplementation</keyword>
	<keyword>Randomised control trial</keyword>
</DOC>